Table 2 |
|||
|
Effect of tacrolimus on I/R induced changes in tissue biomarker level |
|||
|
Groups |
Reduced Glutathione (μg/mg of protein) |
MPO Activity (U/min/mg of protein) |
Total Calcium (ppm/mg of protein) |
|
|
|||
|
Normal |
72.64 ± 2.91 |
11.32 ± 1.56 |
3.49 ± 1.04 |
|
Sham |
71.31 ± 2.47 |
12.64 ± 1.37 |
3.59 ± 0.83 |
|
I/R |
39.25 ± 1.67a |
134.01 ± 3.91a |
34.61 ± 1.93a |
|
Vehicle |
40.54 ± 1.92a |
138.43 ± 3.51a |
35.19 ± 1.64a |
|
Tacrolimus (1) |
46.47 ± 2.65a |
126.32 ± 1.47a |
31.69 ± 0.57a |
|
Tacrolimus (2) |
63.35 ± 1.69b |
62.79 ± 2.63b |
14.41 ± 2.61b |
|
Tacrolimus (3) |
68.41 ± 1.83b |
41.84 ± 3.92b |
9.16 ± 1.92b |
|
|
|||
|
Data were expressed as mean ± S.E.M. for each group. a = P < 0.05 vs sham control group, b = P < 0.05 vs ischemia control group. |
|||
|
Muthuraman and Sood Journal of Brachial Plexus and Peripheral Nerve Injury 2010 5:13 doi:10.1186/1749-7221-5-13 |
|||